Amphastar Pharmaceuticals Files 8-K on Financials
Ticker: AMPH · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1297184
| Field | Detail |
|---|---|
| Company | Amphastar Pharmaceuticals, Inc. (AMPH) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: AMPH
TL;DR
Amphastar dropped an 8-K on Feb 27th covering financials - check it for the deets.
AI Summary
Amphastar Pharmaceuticals, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition, as well as filing financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing serves as a public notification of Amphastar Pharmaceuticals' financial reporting and operational updates, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — The filing is a standard regulatory report and does not inherently indicate new risks or significant negative events.
Key Players & Entities
- Amphastar Pharmaceuticals, Inc. (company) — Registrant
- February 27, 2025 (date) — Date of Report
- 11570 6th Street, Rancho Cucamonga, California 91730 (address) — Principal Executive Offices
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text indicates the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not include the specific details of these results or updates.
What is the significance of filing an 8-K for Amphastar Pharmaceuticals?
An 8-K filing is a Current Report required by the SEC to announce major corporate events, including significant financial or operational changes, which is important for public disclosure to investors.
When was this 8-K filing submitted?
The filing was submitted on February 27, 2025.
What is Amphastar Pharmaceuticals' principal executive office address?
The principal executive offices are located at 11570 6th Street, Rancho Cucamonga, California 91730.
What is the Commission File Number for Amphastar Pharmaceuticals?
The Commission File Number for Amphastar Pharmaceuticals is 001-36509.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Amphastar Pharmaceuticals, Inc. (AMPH).